Joe Saseen explains the 2026 dyslipidemia guidelines' push for universal Lp(a) screening, clarifies...
2026 Dyslipidemia Guidelines: New Biomarker Recommendations and Non-Statin Treatment Options
Joe Saseen explains the 2026 dyslipidemia guidelines' push for universal Lp(a) screening, clarifies when ApoB testing adds value, and outlines how new...
Author: Pharmacy Times
Read Original Article